1T-LSD

Edit links
Source: Wikipedia, the free encyclopedia.
1T-LSD
Clinical data
Routes of
administration		By mouth, under the tongue
Identifiers
  • (6aR,9R)-N,N-diethyl-7-methyl-4-(thiophen-2-yl)methanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Chemical and physical data
JSmol)
  • O=C(n1cc2C[C@@H]3C(=C[C@H](CN3C)C(=O)N(CC)CC)c3cccc1c32)c1cccs1

1T-LSD (N1-(thiophene-2-carbonyl)-lysergic acid diethylamide, SYN-L-021) is an

lysergic acid diethylamide (LSD), which has been sold as a designer drug. It was first identified in Japan in 2023 on blotter paper misrepresented as containing 1D-LSD, but which on analysis was determined to contain 1T-LSD instead.[1]

See also

References

  1. S2CID 259374662
    .
Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=1T-LSD&oldid=1222675883"
This page is based on the copyrighted Wikipedia article: 1T-LSD. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy